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In addition to providing a physical compartment for gestation, the fetal membranes
(FM) are an active immunological barrier that provides defense against pathogenic
microorganisms that ascend the gravid reproductive tract. Pathogenic infection of
the gestational tissues (FM and placenta) is a leading known cause of preterm birth
(PTB). Some environmental toxicants decrease the capacity for organisms to mount
an immune defense against pathogens. For example, the immunosuppressive effects
of the widespread environmental contaminant trichloroethylene (TCE) are documented
for lung infection with Streptococcus zooepidemicus. Group B Streptococcus (GBS;
Streptococcus agalactiae) is a bacterial pathogen that is frequently found in the female
reproductive tract and can colonize the FM in pregnant women. Work in our laboratory
has demonstrated that a bioactive TCE metabolite, S-(1, 2-dichlorovinyl)-L-cysteine
(DCVC), potently inhibits innate immune responses to GBS in human FM in culture.
Despite these provocative findings, little is known about how DCVC and other toxicants
modify the risk for pathogenic infection of FM. Infection of the gestational tissues (FM
and placenta) is a leading known cause of PTB, therefore toxicant compromise of FM
ability to fight off infectious microorganisms could significantly contribute to PTB risk.
This Perspective provides the current status of understanding of toxicant-pathogen
interactions in FM, highlighting knowledge gaps, challenges, and opportunities for
research that can advance protections for maternal and fetal health.
Keywords: fetal membranes, toxicant pathogen interactions, preterm birth (PTB), pregnancy, trichloroethylene
(TCE)

INTRODUCTION
Preterm birth (PTB), or birth <37 weeks gestation, is a significant health problem with
lasting consequences. Preterm birth affects more than 1 in 10 babies in the United States as
well as globally (March of Dimes et al., 2012; Martin et al., 2019). Babies born preterm are
at increased risk for numerous adverse health outcomes later in life, including neurological
(Allin et al., 2006), lung (Pike and Lucas, 2015), and intestinal issues (Behrman et al.,
2007). In a recent study, Grosse et al. (2017) estimated total medical costs associated with
PTB in the United States to be between $6 and 14 billion per year. The fetal membranes
(FM), which surround and protect the fetus during pregnancy, play a critical role in
both term and preterm labor. In addition to providing a physical barrier, the FM are an
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important line of defense against pathogenic microorganisms
that ascend the reproductive tract (Romero et al., 2007). Notably,
pathogenic infection of the gestational tissues (FM and placenta)
is a leading known cause of PTB (Goldenberg et al., 2000, 2008).
Epidemiology studies have identified a diverse array of factors
associated with PTB (Goldenberg et al., 2008; Ferguson et al.,
2013, 2019; Torchin and Ancel, 2016; Vogel et al., 2018). These
include exposure to a range of toxic substances including air
pollution (Liu et al., 2019), cigarette smoke (Soneji and BeltranSanchez, 2019), polyfluoroalkyl substances (Sagiv et al., 2018),
polybrominated diphenyl ethers (PBDEs; Peltier et al., 2015),
phthalate esters (Ferguson et al., 2014), lead (Taylor et al., 2015),
and arsenic (Ahmad et al., 2001). Additional factors include
infection with pathogenic bacteria (Bianchi-Jassir et al., 2017)
and exposure to high outdoor air temperatures (Zhong et al.,
2018; Gronlund et al., 2020). On a mechanistic basis, these
exposures are thought to act by triggering oxidative stress and/or
inflammatory pathways that are part of the normal labor process
of weakening the membranes (Menon et al., 2011; Romero et al.,
2014; Wallace et al., 2016; Ha et al., 2018). While biologically
plausible, these mechanisms remain poorly understood.
Despite
known
examples
of
toxicant-induced
immunosuppression occurring in organs such as the lung
(Aranyi et al., 1986; Mitchell et al., 2009; Selgrade and Gilmour,
2010), toxicant mediation of immune responses to bacterial
infection in FM is largely unexplored. This review focuses on
our current understanding about environmental toxicants,
pathogenic bacteria and interactions between the two in FM.
Due to the potential lifelong health impacts of PTB (Allin et al.,
2006; Behrman et al., 2007; Pike and Lucas, 2015) and the critical
role that the membranes play in healthy pregnancy (Menon and
Moore, 2020), a deeper understanding of these interactions has
significant public health implications.

secrete increasingly more cytokines and chemokines, which leads
to prostaglandin synthesis and release (Mesiano, 2007; Kota
et al., 2013) as well as immune cell recruitment in the gestational
compartment (Osman et al., 2003). Because the FM abut the
uterine muscle (myometrium), they are important as a source of
prostaglandins that stimulate uterine contractions in labor.
Furthermore, in normal pregnancies, FM undergo a process
of weakening leading up to rupture soon after the start of uterine
contractions (Menon, 2016; Menon et al., 2016). Molecular
signaling pathways, such as oxidative stress and inflammation,
as well as mechanical forces contribute to the weakening of
the membranes near term, a process characterized by cellular
senescence and aging of the membranes (Menon et al., 2016).
Rupture usually occurs in a structurally weak region of the
membranes with a thinner chorion that overlies the cervix,
referred to as the zone of altered morphology (ZAM; McLaren
et al., 1999; McParland et al., 2003; Marcellin et al., 2017).
Premature rupture of the FM, or PROM, is characterized by
rupture of the FM more than one hour before the onset of labor.
PROM occurring after 37 weeks of pregnancy typically presents
relatively few complications. However, pPROM, or preterm
premature rupture of the FM (i.e., PROM that occurs prior to
37 weeks of gestation) is associated with severe adverse pregnancy
outcomes and is frequently associated with asymptomatic
intrauterine infection (Mercer, 2004; Caughey et al., 2008; Huang
et al., 2018). Examples of associated adverse neonatal outcomes
include respiratory distress syndrome, pulmonary hypoplasia
(Nourse and Steer, 1997; Linehan et al., 2016), and neurological
outcomes (Manuck and Varner, 2014). pPROM affects around
1–3% of pregnancies (Huang et al., 2018).

ANATOMY AND FUNCTION OF THE
FETAL MEMBRANES

Intrauterine bacterial infection is well established as a cause
of PTB (Romero et al., 2014). It is estimated that intrauterine
infection accounts for at least 25–40% of PTBs (Goldenberg
et al., 2008). Both placenta and FM from preterm and
pPROM pregnancies have been shown to be more likely to
contain bacterial DNA and a higher level of diversity in
bacterial species compared to term pregnancies (Jones et al.,
2009). Pathogenic bacteria associated with pPROM and PTB
include species from genera such as Staphylococcus, Escherichia,
Mycoplasma, Ureaplasma, and Streptococcus (Larsen and Hwang,
2010; Oh et al., 2010; Fortner et al., 2014; Zeng et al., 2014;
Kong et al., 2019).
The predominant mechanism by which bacteria enter
the gestational compartment causing intrauterine infection is
through the ascending pathway by which bacteria first colonize
the vagina and cervix, migrate to and then cross the FM, and then
colonize the amniotic cavity and fetus (Goldenberg et al., 2000).
Therefore, the FM play a critical role as a barrier to bacterial entry.
In addition to providing a physical barrier to protect
against infection, the FM provide crucial immunological defense
against pathogenic microorganisms that ascend the reproductive
tract. The FM actively secrete antimicrobial peptides, such as

FETAL MEMBRANES AS A TARGET OF
BACTERIAL PATHOGENS

The FM are a heterogenous tissue with multiple cell types that
make up two distinct layers, the inner amnion (surrounding the
fetus) and the outer chorion (Strauss, 2013). The amnion layer is
composed of a single amnion epithelial cell layer and dense layer
of collagen fibrils synthesized by fibroblasts (Verbruggen et al.,
2017). The chorion is composed of trophoblasts that are in close
contact with maternally derived decidual cells (Wang et al., 2018;
Menon and Moore, 2020). The FM also include a small number
of resident innate immune cells (macrophages and monocytes)
(Osman et al., 2003).
The culmination of a healthy pregnancy is marked with
increased prostaglandin secretion, activation of matrix
metalloproteinases, and recruitment of immune cells, leading to
myometrial contractions, rupture of the membranes, and cervical
ripening, respectively (Vadillo-Ortega et al., 1996; HernandezGuerrero et al., 2000; Challis et al., 2009; Yellon, 2019). Although
our understanding of the role of FM in the initiation of labor
remains incomplete, it is widely accepted that they contribute
to the parturition pathway. As pregnancy progresses, the FM
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fluid. Numerous epidemiology studies have found associations
between exposures to environmental toxicants and increased
risk of pPROM. These include toxic substances such as lead
(Huang et al., 2018), ambient air pollution (Wang et al., 2019)
and cigarette smoke (England et al., 2013). These epidemiology
studies along with the detection of toxicants in human FM
support the role of FM as a target of toxicant effects related to
adverse pregnancy outcomes.

human beta defensins, lactoferrin, and cathelicidin, to inhibit
bacterial infection (Kjaergaard et al., 1999; King et al., 2007a,b;
Boldenow et al., 2013). Furthermore, the choriodecidual cells as
well as resident innate immune cells are capable of secreting
proinflammatory cytokines such as IL-1β, IL-6, IL-8, and TNFα, which help signal for additional immune cell recruitment
(Challis et al., 2009; Yockey and Iwasaki, 2018). Proinflammatory
cytokines can also potentially trigger increased release of
prostaglandins and proteases, which are key molecular triggers
of parturition (Norwitz et al., 1992; Mitchell et al., 1993; Brown
et al., 1998; Young et al., 2002; Myatt and Sun, 2010; Romero
et al., 2014). Even when bacteria do not infect the amniotic
compartment, these proinflammatory responses to bacterial
infection in the FM can lead to adverse pregnancy and neonatal
outcomes (Adams Waldorf et al., 2011; Burd et al., 2012; GarciaFlores et al., 2018).
Much of what is currently known about toxicant-bacteria
interactions in FM comes from experiments using either
Streptococcus agalactiae, commonly known as Group B
Streptococcus (GBS). Group B Streptococcus infection in pregnant
women is the leading cause of infectious neonatal morbidity
and mortality in the United States (Verani et al., 2010).
Group B Streptococcus induces preterm labor in non-human
primates (Gravett et al., 1996; Boldenow et al., 2016). In women,
GBS infection is associated with PTB at less than 32 weeks
gestation (Hillier et al., 1991) and with chorioamnionitis, an
inflammation of the chorion layer of the FM (Anderson et al.,
2007). A recent publication from our laboratory showed that
GBS inoculation caused a release of molecular effectors of
parturition (matrix metalloproteinases and prostaglandin E2)
from human FM explant punches in vitro (Park et al., 2018).
In addition, pathway analysis of transcriptomic responses
showed that pathways related to inflammation and PTB were
activated by GBS inoculation (Park et al., 2018). Studies from
our laboratory showed that a metabolite of trichloroethylene
(TCE), a common environmental contaminant, modifies innate
immune response to GBS in FM explants (Boldenow et al., 2015).
Other groups have shown similar effects with other toxicantbacteria combinations (e.g., carbon monoxide and Escherichia
coli (Klimova et al., 2013). Although rarely explored, interactive
effects between pathogens and toxicants in gestational tissues
are plausible and have significant implications for maternal
and fetal health.

Toxicants Activate Pathways Involved in
Fetal Membrane Rupture and PTB
Consideration of the FM as a mediator of toxicant effects is
plausible based on their important role in membrane rupture
and in the initiation of labor. As recently reviewed by Menon
(2016), Menon et al. (2019), and Menon and Moore (2020), the
FM contribute to the activation of labor and membrane rupture
through a variety of molecular signaling pathways involving
hormones, inflammatory cytokines, phosphorylated MAPK p38,
reactive oxygen species and prostaglandins. Pro-inflammatory
cytokines such as IL-1β, TNF-α, and IL-8 are secreted by
the FM and promote the production of prostaglandins and
proteases in the gestational compartment (Norwitz et al., 1992;
Mitchell et al., 1993; Brown et al., 1998; Young et al., 2002;
Myatt and Sun, 2010). Prostaglandins play a direct role in
stimulating uterine contractions and cervical ripening, and
proteases and ROS contribute to the weakening of the FM
(Woods, 2001; Romero et al., 2014). The p38 MAPK pathway
is critical for the initiation of cellular senescence and FM
weakening, ultimately leading to membrane rupture (Menon
et al., 2014). Increased generation of ROS in the gestational
compartment is thought to activate the p38 pathway, leading to
membrane senescence, damage to collagen, and weakening of the
membranes in preparation for rupture in both term labor and
pPROM (Woods, 2001).
Toxicants such as cigarette smoke extract and PBDEs
activate one or more of these pathways in in vitro models
of FM tissue or cells. For example, PBDEs induced oxidative
stress, p38 MAPK activation and increased expression of
cyclooxygenase-2 (a rate limiting enzyme of prostaglandin
production) in human amnion epithelial cells (Behnia et al.,
2015). Similarly, Menon et al. (2014) showed that cigarette smoke
extract induced oxidative stress (assessed via formation of 3nitrotyrosine staining) and activated the p38 MAPK pathway in
FM explants in vitro. In addition, the environmental contaminant
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), often referred to
as dioxin, increased expression of protease genes in human
amnion epithelial cells (Abe et al., 2006) and increased a
marker of senescence (β-galactosidase) in a FM “organ-onchip” system consisting of primary human amnion epithelial
cells co-cultured with decidual cells (Richardson et al., 2019).
Thus, toxicology studies support molecular mechanisms that may
explain epidemiological associations between toxicant exposures
and adverse pregnancy outcomes mediated by the FM. However,
several aspects of these phenomena, such as the thresholds of
exposure and potential dimorphic responses based on fetal sex,
remain largely unexplored.

FETAL MEMBRANES AS A TARGET OF
ENVIRONMENTAL TOXICANTS
Pregnant women are exposed to a multitude of diverse
environmental contaminants through drinking water, food
packaging, air pollution workplace exposures, and other sources
(Mitro et al., 2015). Ubiquitous environmental contaminants
such as lead, cadmium, PBDEs, bisphenol A, and phthalates
have been detected in human FM (Miller et al., 2009; Kot et al.,
2019) and amniotic fluid (Miller et al., 2012; Geer et al., 2015),
demonstrating that contaminants can come into contact with the
FM either through blood flow to the decidua or via the amniotic
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FIGURE 1 | Proposed model of TCE immunosuppression in fetal membranes leading to increased susceptibility to GBS infection during pregnancy.

IL-10 secretion (Peltier et al., 2013). Notably, the PBDE and
TCDD effects were observed in the absence of impacts on
explant viability and in placenta tissue obtained from both
term (Arita et al., 2018c) and preterm (Peltier et al., 2012,
2013) stages of pregnancy, suggesting that immunomodulatory
effects can occur throughout gestation. In addition, tributyltin
enhanced E. coli-stimulated IL-6 release from placental explants
(Arita et al., 2018a). Another study found that the flame
retardant chemical tetrabromobisphenol A (TBBPA) increased
the E. coli-induced release of IL-6 and TNF-α (Arita et al.,
2018b). Research continues to be limited on how these toxicants
modify bacterial host response in the FM and in vivo. Given
the important nature of the FM in pPROM and PTB it
is imperative that more research be conducted on toxicantpathogen interactions in the FM.

TOXICANT-PATHOGEN INTERACTIONS:
IMPACT ON FETAL MEMBRANES
Whereas several mechanisms have been identified which present
plausible explanations for FM toxicity, immunomodulation
in conjunction with bacterial infection remains an important
but understudied phenomenon in gestational tissues. In a
2010 review, Feingold et al. (2010) highlighted the need for
environmental toxicology research to incorporate interactions
with infectious pathogens such as bacteria and viruses. Feingold
et al. (2010) described four potential toxicant-pathogen
interactions that could lead to disease: (1) toxicant and pathogen
are both needed to cause disease; (2) pathogen and toxicant
are individually capable of causing disease; (3) the chemical
toxicant modifies the pathogen which leads to disease; and
(4) the pathogen modifies the toxicant which leads to disease.
In the same journal issue, Birnbaum and Jung (2010) called
for increased attention to environmental health and infectious
disease, noting that they can act concurrently, antagonistically,
or synergistically. Despite this call to action, little research on
toxicant-pathogen interactions during pregnancy has been
conducted in the last decade.

Immunosupression as a Mechanism
of Toxicity
Whereas some toxicants enhance inflammation and immune
responses, others have demonstrated immunosuppressive
effects (Selgrade, 2007). Examples of toxic substances that
suppress immune responses include alcohol, cigarette
smoke, and air pollution, all of which have been shown
to inhibit macrophage phagocytosis (Karavitis and Kovacs,
2011). Epidemiology studies have found associations
between decreased antibody responses to vaccinations
in children exposed to perfluorinated compounds
(Grandjean et al., 2012) and polychlorinated biphenyls
(Heilmann et al., 2006). Immunosuppressive effects of
toxicants have also been observed in gestational tissues.
For example, TBBPA and tributyltin both inhibited
bacteria-stimulated IL-1β secretion in placental explants
(Arita et al., 2018a,b).

Toxicant-Pathogen Co-treatment Leads
to Enhanced Inflammation
Some toxicants have been shown to enhance pathogenstimulated oxidative stress pathways and pro-inflammatory
responses in gestational tissues. For example, some PBDEs
increased E. coli-stimulated IL-1β and IL-6 secretion and
COX-2 expression, as well as reduced E. coli-stimulated IL10 release in human placental explants (Peltier et al., 2012;
Arita et al., 2018c). Similarly, TCDD increased bacteriastimulated PGE2 and COX-2 gene expression and decreased
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FIGURE 2 | Proposed pathways for toxicant activation or suppression of inflammation/immune responses in the fetal membranes with potential implications for
pregnancy outcomes. Multiple environmental toxicants have been identified that either enhance or suppress immune responses in the fetal membranes, particularly
in models of pathogenic infection. Both mechanisms of toxicity have potentially significant implications for adverse pregnancy outcomes, e.g., early activation of
labor pathways (activation) or decreased capacity for membrane tissue to mount a defense against pathogens (suppression). These pathways may not be mutually
exclusive.

Immunomodulatory Effects of
Trichloroethylene

800 Environmental Protection Agency-designated Superfund
sites (Wong, 2004; Chiu et al., 2013). Trichloroethylene is
classified as a “known human carcinogen” (Guha et al., 2012)
and is a renal and hepatic toxicant However, effects of TCE
on gestational tissues have been minimally explored. Because
of its continued industrial use and widespread persistent
environmental contamination, TCE exposure continues to pose
a threat to human health through ingestion of contaminated
drinking water and inhalation of the volatilized chemical
(Watson et al., 2006; Dumas et al., 2018). Trichloroethylene and

The common environmental contaminant TCE is a welldocumented example of a compound with immunosuppressive
effects. Trichloroethylene is a chlorinated volatile organic solvent
commonly used as an industrial metal degreaser (Waters
et al., 1977; Chiu et al., 2013). Trichloroethylene is ranked
#16 on the U.S. Agency for Toxic Substances and Disease
Registry’s Priority List of Hazardous Substances and is a
common environmental contaminant found in approximately
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Ginsburg, 2002), suggesting that the observed effects were not
pathogen specific.
Suppression of cytokine expression has important
implications for innate immune responses in FM. Cytokines
play important roles during bacterial infection, such as the
recruitment of immune cells. Thus, suppression of these cytokine
responses could lead to decreased recruitment of immune cells
during bacterial infection, leading to prolonged or more severe
pathogenic infections during pregnancy. Prolonged or more
severe infections could in turn lead to pPROM, PTB or other
adverse pregnancy outcomes such as neonatal sepsis.
Figure 1 summarizes the major events in the proposed
mechanism by which TCE exposure could lead to increased
susceptibility to GBS infection. Few epidemiology studies have
assessed associations between TCE exposure and PTB. Studies
thus far have found associations with small for gestational age,
low birth weight and birth defects but not PTB (Bove et al.,
2002; Forand et al., 2012; Ruckart et al., 2014). However, these
studies did not report on presence or absence of maternal
pathogenic infection as a variable and obtaining accurate
assessments of TCE exposure is challenging (Bove et al., 2002).
Future epidemiology studies focusing on potential toxicantpathogen interactions could greatly improve our understanding
of whether phenomena observed in FM models in vitro translate
to in vivo human outcomes.

its metabolites are detected in the blood of pregnant women
exposed via inhalation and transfer across the placenta has been
indicated by detection in the umbilical vein and artery (Beppu,
1968; Laham, 1970). Trichloroethylene and its metabolites are
also found in the placenta and amniotic fluid of exposed pregnant
mice (Ghantous et al., 1986). Thus, the effect of TCE and its
downstream metabolites on gestational tissues in exposed women
is of relevant concern.
The immunomodulatory effects of TCE are well documented
in rodent and epidemiology studies. Mice co-treated with TCE
and Streptococcus zooepidemicus showed increased mortality,
decreased bacterial clearance from the lungs, and decreased
alveolar phagocytosis (Aranyi et al., 1986; Selgrade and Gilmour,
2010). Trichloroethylene also suppressed activity of natural
killer cells isolated from exposed rats (Wright et al., 1991).
Immunosuppressive effects are observed in humans exposed to
TCE. For example, lymphocyte counts as well as circulating
levels of proinflammatory cytokines IL-6 and TNF-α were
lower in exposed workers compared to controls (Hosgood
et al., 2011; Xueqin et al., 2018). In a 2009 review, Cooper
et al. (2009) concluded that “studies in mice and humans
support an etiologic role of TCE in autoimmune disease.” It
appears that metabolism is required for at least some of TCE’s
immunotoxicity, because inhibition of the TCE metabolizing
enzyme CYP2E1 mitigates some of these effects (Griffin et al.,
2000). Despite these compelling findings, few researchers have
investigated this phenomenon in gestational tissues such as the
FM. Because the FM play a vital role in protecting the fetus
and gestational compartment from pathogenic infection during
pregnancy, an increased understanding of how environmental
contaminant exposures modify FM responses to infection could
greatly improve our ability to identify populations at risk for
bacterial infection and associated adverse pregnancy outcomes.

DISCUSSION
Despite intriguing findings, numerous aspects of toxicantpathogen interactions in FM need to be clarified in order to reach
conclusions about the implications for maternal or fetal health
outcomes. Although DCVC suppression of innate immune
responses could exacerbate GBS infection, proinflammatory
pathways are also critical in the activation of parturition,
meaning that DCVC could also suppress activation of labor
processes (Figure 1). A better understanding of mechanisms
underlying these phenomena would clarify the true level of risk
for adverse pregnancy outcomes due to GBS infection combined
with TCE exposure. In addition, findings thus far have only
been observed in FM tissue in vitro. While useful, these models
lack a number of tissue interactions between the decidua and
the chorionic layer of the FM as well as maternal immune
responses to infection. Validating these findings in pregnant
animal models co-treated with GBS and TCE could provide
important clarification in this area. Furthermore, clarification
is needed on whether DCVC is the sole metabolite of TCE
responsible for immunosuppressive effects or if downstream
metabolites play a role. Improved understanding of virulence
factors that allow bacteria such as GBS to evade the defenses of
the FM and colonize the amniotic fluid and/or fetus would also
represent a significant step forward. Fetal sex and gestational
age are other potentially important variables that were not
considered in prior studies of the FM. Finally, TCE is far
from the only toxicant known to have immunosuppressive
effects. For example, perfluorinated chemicals such as
perfluorooctanoic acid have recently generated concern due

TCE Metabolite Suppression of Immune
Responses to Bacteria in Fetal
Membranes
Work in our laboratory demonstrated that the bioactive TCE
metabolite S-(1,2-dichlorovinyl)-L-cysteine (DCVC) inhibits
innate immune responses to GBS. These findings were observed
in FM tissue explants (tissue cultures established from FM
obtained from planned caesarian deliveries). Explants co-treated
with GBS and DCVC showed decreased expression of TNFα, IL-1β, and IL-8 compared to those treated with GBS alone
(Boldenow et al., 2015). Two other TCE metabolites (TCA and
DCA) showed no effect (Boldenow et al., 2015). Importantly,
the concentrations of DCVC used (5–10 µM) were within the
range of metabolite blood concentrations in female volunteers
exposed to airborne TCE at the current occupational exposure
limit (Lash et al., 1999; Agency for Toxic Substances and
Disease Registry, 2007). Moreover, the immunomodulatory
effects of DCVC occurred in the absence of any effect on
overall GBS viability. The cytokine suppression occurred not
only in response to GBS, but also in response to lipoteichoic
acid and lipopolysaccharide (virulence factors expressed by
multiple species of bacteria) (Alexander and Rietschel, 2001;
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to observed immunosuppressive effects (Shane et al., 2020) and
therefore should be investigated for interactions with pathogens
in the context of pregnancy. Other classes of chemicals that
have demonstrated immunosuppressive effects include aromatic
hydrocarbons, benzene and metals such as lead and arsenic
(National Academy of Sciences, 1992).
Some studies have noted both immunosuppressive and
immune activation effects for the same toxicant. For example,
Arita, et al. observed an increase in E. coli-induced TNF-α in
placental explants treated with TBBPA, whereas IL-1β secretion
was reduced (Arita et al., 2018b). This is not surprising given
the inherent complexity of immunological signaling pathways.
For a given toxicant, it is possible that both immune activation
and suppression could occur to differing degrees simultaneously
or in sequence, which is especially important to recognize when
utilizing in vitro models. For example, if cultured FM are exposed
to the toxicant and pathogen simultaneously then the toxicant
may not diffuse into the tissue before the pathogen stimulates the
early TNF-α response, but the toxicant could still inhibit the later
IL-1β response. Additionally, the toxicant may act to inhibit or
activate different molecular pathways within the immune system.
For example, the toxicant could be inhibiting caspase, which is
needed for IL-1β secretion, while simultaneously activating TNFα (Thornberry et al., 1992). If immune activation predominates,
adverse pregnancy events may include preterm activation of
labor pathways which could lead to premature rupture of the
FM. If immune suppression is the dominant process, adverse
events could include increased pathogenic infiltration into
the gestational compartment due to inadequate FM immune
response. The mechanisms determining whether suppression or
activation predominate in the FM in response to toxicants are not
currently well understood but are likely mediated by a number of
factors including the dose of toxicant, stage of pregnancy, strain
or species of pathogen or duration of toxicant exposure (e.g.,
chronic vs. acute exposure). For example, naturally occurring
immunological changes occurring throughout pregnancy include
a progressive increase in the number and responsiveness of
circulating neutrophils (Aghaeepour et al., 2017). Therefore,
being exposed to a toxicant and/or pathogen late in pregnancy
may favor immune activation whereas a different response
may be observed with exposure earlier in pregnancy. Whether
toxicant immune activation, suppression or a more complex
interaction between the two, is the most relevant to the FM for a
given toxicant-pathogen interaction is difficult to predict, further
highlighting the need for additional research on this topic.

In summary, limited studies have shown that toxicants can
potentially modify immune responses in the FM through both
“immune/inflammation activation” and “immune/inflammation
suppression” pathways (see Figure 2). Because current research
into these phenomena has relied mostly on in vitro models
of gestational cells and tissues, further research is needed to
determine whether effects observed in vitro are replicated in FM
in vivo. In vitro models are necessarily removed from the inherent
complexity of the in vivo immune system. Studies using animal
models would improve our understanding of how toxicants
affect immune responses in the FM in an intact organism.
Further research could improve our understanding of toxicantpathogen interactions during pregnancy and potentially identify
populations at risk for adverse pregnancy outcomes.
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